Hemostemix Inc (HEM) - Total Liabilities

Latest as of September 2025: CA$4.80 Million CAD ≈ $3.47 Million USD

Based on the latest financial reports, Hemostemix Inc (HEM) has total liabilities worth CA$4.80 Million CAD (≈ $3.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Hemostemix Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Hemostemix Inc's total liabilities have evolved over time, based on quarterly financial data. Explore HEM long-term investment intensity to see how much of total assets are deployed in long-term investments.

Hemostemix Inc Competitors by Total Liabilities

The table below lists competitors of Hemostemix Inc ranked by their total liabilities.

Company	Country	Total Liabilities
AUX Resources Corporation V:AUX	Canada	CA$225.92K
Amalgamated Industrial Steel Berhad KLSE:2682	Malaysia	RM90.89 Million
K2 Asset Management Holdings Ltd AU:KAM	Australia	AU$2.93 Million
American Shared Hospital Service NYSE MKT:AMS	USA	$31.03 Million
Ayo Technology Solutions Ltd JSE:AYO	South Africa	ZAC975.50 Million
Empire Resources Ltd AU:ERL	Australia	AU$1.56 Million
Iron Horse Acquisitions Corp. Common Stock NASDAQ:IROH	USA	$74.95 Million
Ely Gold Royalties Inc V:ELY	Canada	CA$792.13K

Liability Composition Analysis (2013–2024)

This chart breaks down Hemostemix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hemostemix Inc (HEM) total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.54	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	3.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hemostemix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hemostemix Inc (2013–2024)

The table below shows the annual total liabilities of Hemostemix Inc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$8.20 Million ≈ $5.93 Million	+6.65%
2023-12-31	CA$7.68 Million ≈ $5.56 Million	+6.23%
2022-12-31	CA$7.23 Million ≈ $5.23 Million	+23.73%
2021-12-31	CA$5.85 Million ≈ $4.23 Million	+70.87%
2020-12-31	CA$3.42 Million ≈ $2.48 Million	-17.54%
2019-12-31	CA$4.15 Million ≈ $3.00 Million	+253.31%
2018-12-31	CA$1.17 Million ≈ $849.58K	+152.68%
2017-12-31	CA$464.79K ≈ $336.22K	-87.40%
2016-12-31	CA$3.69 Million ≈ $2.67 Million	+492.45%
2015-12-31	CA$622.73K ≈ $450.47K	+12.87%
2014-12-31	CA$551.70K ≈ $399.09K	+127.05%
2013-12-31	CA$242.98K ≈ $175.77K	--

About Hemostemix Inc

V:HEM Canada Biotechnology

Market Cap

$8.86 Million

CA$12.25 Million CAD

Market Cap Rank

#27370 Global

#1157 in Canada

Share Price

CA$0.07

Change (1 day)

-7.14%

52-Week Range

CA$0.05 - CA$0.13

All Time High

CA$13.40